Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Multiple pharmacy

Walgreen Boots Alliance sees earnings rise by nearly 40%

Walgreens Boots Alliance, has reported a 39.9% increase in its third quarter net earnings to US$1.1bn for the period ending 31 May 2015. Stefano Pessina (pictured), newly appointed chief executive officer of the group.

Source: Walgreens Boots Alliance

Walgreens Boots Alliance has announced the promotion of its acting chief executive officer, Stefano Pessina, to CEO

The largest retail pharmacy, health and daily living group in the United States and Europe, Walgreens Boots Alliance, has reported a 39.9% increase in its third quarter net earnings to US$1.1bn for the period ending 31 May 2015. The group, created in December 2014 as a combination of Walgreens and Alliance Boots, also saw healthy third quarter sales, increasing by 48.4% to US$28.8bn compared with the previous period.

For its US retail pharmacy segment, whose principal pharmacy brands are Walgreens and Duane Reade, third quarter sales totalled US$20.4bn, an increase of 5.3% over 2014. Retail sales grew by 1.6% and pharmacy sales grew by 7.0%. In the first nine months of fiscal 2015, 104 drugstores opened, and 37 closed.

For its retail pharmacy international division, whose principal brand is Boots in the UK and other countries, third quarter sales were US$3.3bn, with a net increase of six stores over the quarter.

The results follow its April 2015 announcement of a US$1.5bn cost savings programme post-merger. So far, the company has closed nine US stores, expected to rise to 70–80 by the end of this fiscal year, and 200 by the end of fiscal year 2017. The retail pharmacy international segment will lose around 700 non-store-based roles, through attrition and redundancies.

The group’s pharmaceutical wholesale division had third quarter sales of US$5.7bn, an increase of 0.2% over 2014. The group also announced the promotion of its acting chief executive officer, Stefano Pessina, to CEO. 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068946

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Walgreens Boots Alliance, has reported a 39.9% increase in its third quarter net earnings to US$1.1bn for the period ending 31 May 2015. Stefano Pessina (pictured), newly appointed chief executive officer of the group.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.